FDA Alerts

fda alert
FDA Alert
fda alert
FDA Converts Alzheimer Disease Treatment to Traditional Approval
07/28/2023

Leigh Precopio

Leigh Precopio
The FDA has examined the results of a recent confirmatory trial to verify the clinical benefit of an amyloid beta-directed antibody for the treatment of Alzheimer disease.
07/28/2023
FDA Alert
fda
FDA Alert
FDA Approves First Treatment of Agitation in Patients With Alzheimer Dementia
05/15/2023

Jessica Ganga

Jessica Ganga
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
05/15/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
The FDA approved a treatment that targets one of the main causes of Alzheimer disease.
01/10/2023
FDA
FDA
FDA Approves First Tau Pathology Drug
05/29/2020
The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
05/29/2020
FDA Roundup
FDA Roundup
Key FDA Approvals Include First OTC, Nonprescription Daily Oral Contraceptive, First Monoclonal Injection to Prevent RSV in Infants, and More
07/28/2015

Anthony Calabro, MA

Anthony Calabro, MA
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...
07/28/2015